Atlas Trials

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus

Clinical trial NCT04355052 · UNKNOWN

Trial details

NCT number
NCT04355052
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID - 19
Start date
2020-04-11
Primary completion
2020-10-11
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.